What is the recommended dose of albumin (human albumin) and administration duration in hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Human Albumin Dosing Guidelines

The recommended dose of human albumin varies by clinical indication, with 8 g/L of ascites removed for large-volume paracentesis (>5L) and 1.5 g/kg followed by 1 g/kg on day 3 for spontaneous bacterial peritonitis being the most evidence-based regimens. 1, 2

Dosing Recommendations by Clinical Indication

Large-Volume Paracentesis (>5L)

  • Dose: 8 g albumin per liter of ascites removed 1, 2
  • Administration timing: Immediately after paracentesis completion 2
  • Formulation: 20% or 25% albumin solution 1
  • Evidence strength: High quality evidence with strong recommendation 2, 3

Spontaneous Bacterial Peritonitis (SBP)

  • Dose: 1.5 g/kg within 6 hours of diagnosis, followed by 1 g/kg on day 3 1, 4
  • Target population: Particularly beneficial in patients with increased serum creatinine or rising serum creatinine 1
  • Rationale: Reduces risk of renal dysfunction by 72% and mortality by 47% 1, 4
  • Note: Some small studies suggest lower doses may be effective, but the standard regimen has the strongest evidence 1

Hepatorenal Syndrome (HRS-AKI)

  • Dose: 20-40 g/day alongside vasoconstrictors 1
  • Duration: Optimal duration remains unclear, but continued until response 1
  • Administration: Intravenous infusion 1

Severe Burns

  • Dose: 1-2 g/kg/day for patients with >30% total burned body surface area 1
  • Timing: After the first 6 hours of management 1
  • Target: Maintain albumin levels >30 g/L 1
  • Rationale: Decreases crystalloid administration and resulting morbidity 1

Acute-on-Chronic Liver Failure (ACLF)

  • Dose: 6-8 g/L of ascites removed regardless of volume 1, 2
  • Special consideration: Albumin administration recommended even for paracentesis <5L in these high-risk patients 2

Administration Guidelines

Rate of Administration

  • Administer slowly to prevent circulatory overload 2
  • Monitor for signs of volume overload, especially in patients with cardiac dysfunction 2

Monitoring Parameters

  • Hemodynamic parameters
  • Signs of volume overload
  • Renal function
  • Electrolytes 2

Clinical Considerations and Pitfalls

Common Pitfalls

  1. Overuse in non-indicated conditions: Albumin should not be used routinely for:

    • Hypoalbuminemia without specific indications 3
    • Nutritional support 3
    • Infections other than SBP (unless associated with AKI) 1
    • Uncomplicated ascites with diuretics 1
  2. Potential adverse effects:

    • Fluid overload
    • Pulmonary edema
    • Hypotension/tachycardia
    • Pyrexia
    • Rash/pruritus 1
  3. Excessive dosing: Doses of HAS exceeding 87.5 g in SBP may be associated with worse outcomes due to fluid overload 1

Special Populations

  • Pediatric burns patients: Early administration (8-12 hours post-burning) of 5% albumin decreases crystalloid requirements and fluid creep 1
  • Patients with cardiac dysfunction: Require careful monitoring for volume overload 2

Conclusion

Human albumin dosing should be tailored to the specific clinical indication, with the strongest evidence supporting its use in large-volume paracentesis and spontaneous bacterial peritonitis. Administration should follow evidence-based protocols to maximize benefits while minimizing potential adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Paracentesis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Albumin: a comprehensive review and practical guideline for clinical use.

European journal of clinical pharmacology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.